Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 11Pancreatic Neoplasms 8Stomach Neoplasms 4Colorectal Neoplasms 3Pancreatic cancer, adult 2Squamous Cell Carcinoma of Anal Canal 1Resectable Pancreatic Cancer 1Pancreatic Cancer Resectable 1Neoplasm Metastasis 1Locally Advanced Rectal Cancer 1Esophageal 1Advanced Pancreatic Cancer 1Advanced Esophageal 1Advanced Colorectal Cancer 1Adenocarcinoma 1

Interventions

Fluorouracil 98Oxaliplatin 94Leucovorin 86Irinotecan 70Gemcitabine 66Bevacizumab 62Capecitabine 60Cetuximab 42pembrolizumab 37Cisplatin 30Nivolumab 25Drug Therapy 25130-nm albumin-bound paclitaxel 22Specimen Handling 20Folfox protocol 20Panitumumab 19Paclitaxel 19Magnetic Resonance Spectroscopy 18Albumin-Bound Paclitaxel 17Biopsy 16IFL protocol 15Floxuridine 15Docetaxel 15Cyclophosphamide 15Sorafenib 14regorafenib 12Erlotinib Hydrochloride 12aflibercept 11Radiofrequency Ablation 11fludarabine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × nimotuzumab × Gastrointestinal × Clear all
NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

Oncoscience AG

Phase 2/3 Completed
188 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡